Immunic
IMUX
Immunic (IMUX) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.80
- EPS estimate
- −$1.16
- EPS surprise
- +31.32%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Aug 11, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 11, 2026 | −$1.16 | −$0.80 | +31.32% | $0.00 | SEC |
| Q2 2025 | Aug 7, 2025 | −$1.58 | −$2.00 | −26.74% | $0.00 | SEC |
| Q1 2025 | May 15, 2025 | −$2.40 | −$2.50 | −4.17% | $0.00 | SEC |
| Q4 2024 | Mar 31, 2025 | −$2.35 | −$2.50 | −6.38% | $0.00 | SEC |
| Q3 2024 | Nov 7, 2024 | −$2.18 | −$2.40 | −9.89% | $0.00 | SEC |
| Q2 2024 | Aug 8, 2024 | −$2.33 | −$2.10 | +9.68% | $0.00 | SEC |
| Q1 2024 | May 8, 2024 | −$2.60 | −$3.00 | −15.38% | $0.00 | SEC |
| Q4 2023 | Feb 22, 2024 | −$5.13 | −$4.80 | +6.34% | $0.00 | SEC |
| Q3 2023 | Nov 14, 2023 | −$5.48 | −$5.10 | +6.85% | $0.00 | SEC |
| Q2 2023 | Aug 3, 2023 | −$5.25 | −$5.40 | −2.86% | $0.00 | SEC |
| Q1 2023 | May 11, 2023 | −$5.18 | −$5.80 | −12.08% | $0.00 | SEC |
| Q4 2022 | Feb 23, 2023 | −$7.33 | −$16.30 | −122.53% | $0.00 | SEC |
| Q3 2022 | Nov 3, 2022 | −$6.70 | −$6.90 | −2.99% | $0.00 | — |
| Q2 2022 | Aug 4, 2022 | −$7.32 | −$7.20 | +1.64% | $0.00 | — |
| Q1 2022 | May 10, 2022 | −$8.09 | −$7.40 | +8.48% | $0.00 | — |
| Q4 2021 | Feb 24, 2022 | −$7.66 | −$7.20 | +6.04% | $0.00 | — |
| Q3 2021 | Nov 4, 2021 | −$8.05 | −$7.60 | +5.59% | $0.00 | — |
| Q2 2021 | Aug 6, 2021 | −$6.84 | −$8.20 | −19.93% | $0.00 | — |
| Q1 2021 | May 6, 2021 | −$6.95 | −$16.30 | −134.53% | $0.00 | — |
| Q4 2020 | Feb 26, 2021 | −$6.82 | −$4.20 | +38.42% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did Immunic (IMUX) last report earnings?
Immunic last reported on Aug 11, 2026, covering fiscal Q2 2026.
Did IMUX beat earnings estimates?
Yes. Immunic reported EPS of −$0.80 for Q2 2026 against a −$1.16 estimate — a 31.32% beat.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.